Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review
Only about 50% of patients with treatment-resistant schizophrenia respond to clozapine, and many more patients continue to experience ongoing and prominent negative symptoms. These negative symptoms, for which there are limited pharmacological options, may represent the greatest barrier to functiona...
Saved in:
Main Authors: | Ebenezer Oloyede (Author), Ivana Clark (Author), Shubhra Mace (Author), Eromona Whiskey (Author), David Taylor (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cariprazine augmentation of clozapine in schizophrenia-a retrospective chart review
by: Marcin Siwek, et al.
Published: (2024) -
Efficacy and safety of cariprazine augmentation in patients treated with clozapine: a pilot study
by: Sofia Pappa, et al.
Published: (2022) -
Clozapine discontinuation withdrawal symptoms in schizophrenia
by: Graham Blackman, et al.
Published: (2021) -
Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation
by: Farinaz Keshavarzi, et al.
Published: (2020) -
Management of clozapine treatment during the COVID-19 pandemic
by: Siobhan Gee, et al.
Published: (2020)